Drugs that contain Nimodipine
1. List of Nymalize drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7070581 | AZURITY | Dispenser for medicaments and method and apparatus for making same |
Jun, 2023
(14 days from now) | |
| US8517997 | AZURITY | Dispenser for medicaments and method and apparatus for making same |
May, 2024
(11 months from now) | |
| US10576070 | AZURITY | Non-aqueous liquid nimodipine compositions |
Apr, 2038
(14 years from now) | |
| US11207306 | AZURITY | Non-aqueous liquid nimodipine compositions |
Apr, 2038
(14 years from now) | |
| US10342787 | AZURITY | Non-aqueous liquid nimodipine compositions |
Apr, 2038
(14 years from now) | |
| US11413277 | AZURITY | Non-aqueous liquid nimodipine compositions |
Apr, 2038
(14 years from now) | |
| US11517563 | AZURITY | NA |
Apr, 2038
(14 years from now) | |
Market Authorisation Date: 10 May, 2013
Treatment: A method for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in adult patients with subarachnoid hemorrhage (sah) from ruptured intracranial berry a...
Dosage: SOLUTION;ORAL
How can I launch a generic of NYMALIZE before it's patent expiration?
More Information on Dosage
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic